1/3
Net Contents:   3 x 0.5 mL

ADP is for use in routine platelet aggregation studies for the evaluation of inherited or acquired platelet dysfunction, anti-platelet therapy or platelet activation.

  • Elicits Platelet Shape Change

  • Measure Disaggregation

  • Detect P2Y1, P2Y12, and IIb IIIa Inhibitors

  • Monitor LVAD Implant Effects on Platelet Function

  • Extended Three Year Shelf Life

Catalog No.  101312

ADP

Adenosine-5'-Diphosphate

PRODUCT DETAILS

When added to platelet rich plasma, ADP stimulates platelets to change their shape and aggregate.

English_Flag.png
Spanish_Flag.png
French_Flag.png
German_Flag.png
Italy_Flag.png

Aggregation induced by exogenous ADP is referred to as primary aggregation and is reversible. Normal platelets will further respond by releasing endogenous ADP from their granules. Release of endogenous ADP results in a secondary wave of aggregation which is irreversible

YOU MAY ALSO BE INTERESTED IN:

AggRecetin®

15mg

AggRecetin%20Box%20and%20Vials%20020620%

Beta/PAK®

BetaPak%20Box%20and%20Vials%20020620%20C

Collagen

Collagen%20Box%20and%20Vials%20020620%20

Epinephrine

Par/PAK® II